Dianthus Therapeutics Inc. (DNTH)
NASDAQ · Healthcare
Dianthus Therapeutics Inc. EPS 2016–2025
Dianthus Therapeutics Inc. annual/quarterly eps history and growth rate from 2023 to 2025. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Dianthus Therapeutics Inc. eps for the quarter ending September 30, 2025 was $0.97, a 31.08% increase year-over-year.
- Dianthus Therapeutics Inc. annual eps for 2025 was $4.20, a 64.71% increase from 2024.
- Dianthus Therapeutics Inc. annual eps for 2024 was $2.55, a 69.82% decrease from 2023.
- Dianthus Therapeutics Inc. annual eps for 2023 was $8.45.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Dianthus Therapeutics Inc. EPS — FAQ
Dianthus Therapeutics Inc. (DNTH) eps over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Dianthus Therapeutics Inc.'s eps?
Dianthus Therapeutics Inc. (DNTH) reported eps of $-4.20 for fiscal 2025.
Where can I see DNTH's eps history?
The chart and table above show Dianthus Therapeutics Inc.'s eps by year and by quarter, including the growth rate.